Back to search

National and Kapodistrian University of Athens

Μεταβονομική μελέτη κυτταρικών σειρών διαφόρων τύπων καρκίνου και καρκινικών ιστών

Abstract

dc:description

Over the last decades cancer is one of the main causes of death for the global population, with the most common types being lung, prostate, and colon cancer in men, and breast, colon, and cervical cancer in women. Adriamycin belongs to the general category of anthracyclines and it is an antineoplastic agent that is non-covalently bound to DNA. It has a large therapeutic range and so it has been widely used as a chemotherapeutic for more than 30 years, both on its own and in co-treatment schemes with other antineoplastic agents for the treatment of breast, ovarian, pancreatic, prostate, osteosarcoma and a number of other cancer types. Despite its potential for cancer cell destruction, adriamycin does not exhibit selectivity in its action, resulting in limitation of its use due to undesirable side effects, including cardiotoxicity and chemoresistance. Previous work carried out in our laboratory has highlighted the beneficial effect of co-treatment of adriamycin with oleuropein, a natural olive-derived product, which can improve the condition of myocardial tissue in normal laboratory animals. In the context of this thesis, the effect of adriamycin and its co-treatment with the antioxidant natural product oleuropein in cancer cell lines and in laboratory animals with cancer was studied. At the cellular level, prostate adenocarcinoma PC-3 and osteosarcoma of osteoblastic phenotype MG-63 were studied. Full-immune system mice were used as model laboratory animals and were inoculated with melanoma (B16.F1) and colon cancer (CT-26) cell lines. MTT cytotoxicity studies in PC-3 and MG-63 cancer cells have shown that co-treatment of adriamycin and oleuropein exhibits an inhibitory effect on the treatment of adriamycin. The cell cycle study showed that in both cell lines both adriamycin and co-treatment lead to cell accumulation in the G2/M phase of the cell cycle. The autophagy mechanism in the MG-63 cell line was tested by quantitating the expression levels of the p62 and NBR1 proteins. Significant alteration relative to the control sample was observed only for the p62 protein for the effects of adriamycin, oleuropein and co-treatment. The effect of co-treatment of adriamycin and oleuropein was also investigated via NMR based metabolomics. A statistical study and comparisons of the metabolic fingerprints of the PC-3 and MG-63 cancer cell lines, as well as of the cancerous tumors, liver, kidney and heart tissues of non-immunosuppressed mice, melanoma (B16.F1) and colorectal cancer (CT-26) xenografts were performed. The effect of gene modification of breast cancer cell line overexpressing the myc protein through metabolomics. The modification was made at exon 20 of the myc gene, and the study was performed in tumors grown in xenografts models from both cell lines, as well as in cell lines grown from the tumors. Adriamycin chemoresistance was investigated by means of the metabolomics in two osteosarcoma cell lines: the U2OS cell line with two chemoresistant sequences and the KHOS cell line for which three chemoresistant sequences have been developed. From the metabolomic analysis, a common group of metabolites emerged which appear in the cancer cell lines and tissues that were isolated and analyzed and appear to play a significant role in the onset and progression of cancer with most characteristic the glutamine, glutamic acid and UDP-N-Acetylglucosamine. The latter is the most interesting in our study as it relates to the biosynthetic pathway of hexosamine. In the case of the PC-3 cell line, all glycosylated proteins were determined by means of the Western blotting technique. The different treatments on cells modify glycosylated proteins, confirming the association with the hexosamine biosynthetic pathway (HBP pathway). The variations in UDP-N-Acetylglucosamine metabolite levels that were observed in several analyzed cell lines and tissues are very interesting and require further investigation.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2018

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Papachristodoulou, Anastasia
  • Παπαχριστοδούλου, Αναστασία

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/45304

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Papachristodoulou, Anastasia; Παπαχριστοδούλου, Αναστασία. Μεταβονομική μελέτη κυτταρικών σειρών διαφόρων τύπων καρκίνου και καρκινικών ιστών. National and Kapodistrian University of Athens, 2018. http://hdl.handle.net/10442/hedi/45304